nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetohydroxamic Acid—MMP12—Matrix Metalloproteinases—MMP14—esophageal cancer	0.166	0.17	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Collagen degradation—MMP14—esophageal cancer	0.137	0.141	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—FKBP1A—esophageal cancer	0.0839	0.0862	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Degradation of the extracellular matrix—MMP14—esophageal cancer	0.0694	0.0713	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—LGALS3—esophageal cancer	0.0549	0.0564	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—CXCL2—esophageal cancer	0.0476	0.0489	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—ANXA1—esophageal cancer	0.0443	0.0455	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—TGFBR2—esophageal cancer	0.0305	0.0314	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—MMP14—esophageal cancer	0.0291	0.0299	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—SMAD4—esophageal cancer	0.0289	0.0297	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—EGFR—esophageal cancer	0.028	0.0288	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—TLR4—esophageal cancer	0.0247	0.0254	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—NOS2—esophageal cancer	0.0235	0.0242	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—MET—esophageal cancer	0.0221	0.0227	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—RB1—esophageal cancer	0.021	0.0216	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—CREBBP—esophageal cancer	0.0193	0.0198	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—PTGS2—esophageal cancer	0.0173	0.0178	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—CCND1—esophageal cancer	0.0156	0.0161	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—CCND1—esophageal cancer	0.0143	0.0147	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—CDKN1A—esophageal cancer	0.0138	0.0142	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—EP300—esophageal cancer	0.0132	0.0135	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Extracellular matrix organization—KDR—esophageal cancer	0.013	0.0133	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—MYC—esophageal cancer	0.0125	0.0129	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—EGFR—esophageal cancer	0.0123	0.0126	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—MYC—esophageal cancer	0.0115	0.0118	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—Spinal Cord Injury—TP53—esophageal cancer	0.0103	0.0106	CbGpPWpGaD
Acetohydroxamic Acid—MMP12—TGF-beta Signaling Pathway—TP53—esophageal cancer	0.00941	0.00967	CbGpPWpGaD
Acetohydroxamic Acid—Gastrointestinal tract irritation—Capecitabine—esophageal cancer	0.00232	0.0863	CcSEcCtD
Acetohydroxamic Acid—Deep vein thrombosis—Capecitabine—esophageal cancer	0.00136	0.0506	CcSEcCtD
Acetohydroxamic Acid—Deep vein thrombosis—Methotrexate—esophageal cancer	0.00101	0.0377	CcSEcCtD
Acetohydroxamic Acid—Haemolytic anaemia—Cisplatin—esophageal cancer	0.000903	0.0336	CcSEcCtD
Acetohydroxamic Acid—Thrombophlebitis—Capecitabine—esophageal cancer	0.000694	0.0258	CcSEcCtD
Acetohydroxamic Acid—Abdominal discomfort—Cisplatin—esophageal cancer	0.000675	0.0251	CcSEcCtD
Acetohydroxamic Acid—Haemolytic anaemia—Capecitabine—esophageal cancer	0.000666	0.0248	CcSEcCtD
Acetohydroxamic Acid—Renal impairment—Capecitabine—esophageal cancer	0.000631	0.0235	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Cisplatin—esophageal cancer	0.000617	0.023	CcSEcCtD
Acetohydroxamic Acid—Lethargy—Capecitabine—esophageal cancer	0.000613	0.0228	CcSEcCtD
Acetohydroxamic Acid—Thrombophlebitis—Methotrexate—esophageal cancer	0.000517	0.0192	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Cisplatin—esophageal cancer	0.000498	0.0185	CcSEcCtD
Acetohydroxamic Acid—Abdominal discomfort—Capecitabine—esophageal cancer	0.000498	0.0185	CcSEcCtD
Acetohydroxamic Acid—Depression—Capecitabine—esophageal cancer	0.000462	0.0172	CcSEcCtD
Acetohydroxamic Acid—Tremor—Cisplatin—esophageal cancer	0.00046	0.0171	CcSEcCtD
Acetohydroxamic Acid—Lethargy—Methotrexate—esophageal cancer	0.000456	0.017	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Cisplatin—esophageal cancer	0.000455	0.017	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Capecitabine—esophageal cancer	0.000455	0.0169	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Cisplatin—esophageal cancer	0.000454	0.0169	CcSEcCtD
Acetohydroxamic Acid—Malaise—Cisplatin—esophageal cancer	0.000443	0.0165	CcSEcCtD
Acetohydroxamic Acid—Anxiety—Cisplatin—esophageal cancer	0.000416	0.0155	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Cisplatin—esophageal cancer	0.000413	0.0154	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Cisplatin—esophageal cancer	0.000382	0.0142	CcSEcCtD
Acetohydroxamic Acid—Abdominal discomfort—Methotrexate—esophageal cancer	0.000371	0.0138	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Capecitabine—esophageal cancer	0.000367	0.0137	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Cisplatin—esophageal cancer	0.000348	0.013	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Cisplatin—esophageal cancer	0.000346	0.0129	CcSEcCtD
Acetohydroxamic Acid—Depression—Methotrexate—esophageal cancer	0.000344	0.0128	CcSEcCtD
Acetohydroxamic Acid—Tremor—Capecitabine—esophageal cancer	0.000339	0.0126	CcSEcCtD
Acetohydroxamic Acid—Renal failure—Methotrexate—esophageal cancer	0.000339	0.0126	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Capecitabine—esophageal cancer	0.000336	0.0125	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Capecitabine—esophageal cancer	0.000334	0.0124	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Cisplatin—esophageal cancer	0.00033	0.0123	CcSEcCtD
Acetohydroxamic Acid—Malaise—Capecitabine—esophageal cancer	0.000326	0.0121	CcSEcCtD
Acetohydroxamic Acid—Palpitations—Capecitabine—esophageal cancer	0.00032	0.0119	CcSEcCtD
Acetohydroxamic Acid—Anxiety—Capecitabine—esophageal cancer	0.000307	0.0114	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Capecitabine—esophageal cancer	0.000304	0.0113	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Cisplatin—esophageal cancer	0.000287	0.0107	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Capecitabine—esophageal cancer	0.000281	0.0105	CcSEcCtD
Acetohydroxamic Acid—Alopecia—Methotrexate—esophageal cancer	0.000273	0.0102	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Capecitabine—esophageal cancer	0.000257	0.00956	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Capecitabine—esophageal cancer	0.000255	0.00949	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Cisplatin—esophageal cancer	0.000255	0.00948	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Capecitabine—esophageal cancer	0.000255	0.00948	CcSEcCtD
Acetohydroxamic Acid—Rash—Cisplatin—esophageal cancer	0.000253	0.0094	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Cisplatin—esophageal cancer	0.000252	0.00939	CcSEcCtD
Acetohydroxamic Acid—Ill-defined disorder—Methotrexate—esophageal cancer	0.00025	0.0093	CcSEcCtD
Acetohydroxamic Acid—Anaemia—Methotrexate—esophageal cancer	0.000249	0.00927	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Capecitabine—esophageal cancer	0.000243	0.00906	CcSEcCtD
Acetohydroxamic Acid—Malaise—Methotrexate—esophageal cancer	0.000243	0.00904	CcSEcCtD
Acetohydroxamic Acid—Nausea—Cisplatin—esophageal cancer	0.000238	0.00886	CcSEcCtD
Acetohydroxamic Acid—Discomfort—Methotrexate—esophageal cancer	0.000227	0.00843	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Capecitabine—esophageal cancer	0.000212	0.00789	CcSEcCtD
Acetohydroxamic Acid—Anorexia—Methotrexate—esophageal cancer	0.00021	0.0078	CcSEcCtD
Acetohydroxamic Acid—Decreased appetite—Methotrexate—esophageal cancer	0.000191	0.00711	CcSEcCtD
Acetohydroxamic Acid—Gastrointestinal disorder—Methotrexate—esophageal cancer	0.00019	0.00706	CcSEcCtD
Acetohydroxamic Acid—Fatigue—Methotrexate—esophageal cancer	0.00019	0.00705	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Capecitabine—esophageal cancer	0.000188	0.00699	CcSEcCtD
Acetohydroxamic Acid—Rash—Capecitabine—esophageal cancer	0.000186	0.00693	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Capecitabine—esophageal cancer	0.000186	0.00692	CcSEcCtD
Acetohydroxamic Acid—Headache—Capecitabine—esophageal cancer	0.000185	0.00689	CcSEcCtD
Acetohydroxamic Acid—Feeling abnormal—Methotrexate—esophageal cancer	0.000181	0.00674	CcSEcCtD
Acetohydroxamic Acid—Nausea—Capecitabine—esophageal cancer	0.000175	0.00653	CcSEcCtD
Acetohydroxamic Acid—Asthenia—Methotrexate—esophageal cancer	0.000158	0.00587	CcSEcCtD
Acetohydroxamic Acid—Vomiting—Methotrexate—esophageal cancer	0.00014	0.0052	CcSEcCtD
Acetohydroxamic Acid—Rash—Methotrexate—esophageal cancer	0.000139	0.00516	CcSEcCtD
Acetohydroxamic Acid—Dermatitis—Methotrexate—esophageal cancer	0.000138	0.00515	CcSEcCtD
Acetohydroxamic Acid—Headache—Methotrexate—esophageal cancer	0.000138	0.00513	CcSEcCtD
Acetohydroxamic Acid—Nausea—Methotrexate—esophageal cancer	0.000131	0.00486	CcSEcCtD
